ubmslateCN-logo-ubm

CN Mobile Logo

Search form

Topics:

STAMPEDE: Front-Line Docetaxel Prolongs Survival in Metastatic Prostate Cancer

STAMPEDE: Front-Line Docetaxel Prolongs Survival in Metastatic Prostate Cancer

 

In this video, Dr. Nicholas David James discusses the results of the STAMPEDE trial, which tested front-line docetaxel combined with hormonal therapy in patients with advanced, hormone-naive prostate cancer.

 
Loading comments...

By clicking Accept, you agree to become a member of the UBM Medica Community.